Table 1.
entry | R3N | δ 11B, ppm | δ 19F, ppm | 12:13 ratio at equilibriumb | |
---|---|---|---|---|---|
1 | Me3N |
12a 13a |
−3.7 4.0 |
−69.2 −77.6, −79.1 |
7:1 |
2 | Et3N |
12b 13b |
−7.4 0.7 |
−68.9 −76.7, −79.1 |
1:4.7 |
3 | (i-Pr)2NEt |
12c 13c |
ND 1.2 |
−68.4 −77.0, −79.1 |
<1:25 |
4 | p-MeBnNMe2 |
12d 13d |
−3.2 4.0 |
−69.0 −76.6, −79.1 |
4.2:1 |
5c |
12e 13e |
−4.6 −0.6 |
−69.2 −76.7, −78.7 |
1:2.6 |
Conditions: 1:1 R3N–BH3:Tf2NH, CD2Cl2, rt.
Monitored up to 2–14 days at rt.
In d8-PhMe.